Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2022-03-31 Declaration of Voting R…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a notification filed via RNS (Regulatory News Service) and explicitly states the purpose is to notify the market of the 'Total Voting Rights' as of a specific date (31 March 2022), referencing DTR 5.6.1R. This filing details the total number of issued ordinary shares with voting rights (108,388,305). This type of announcement, which relates to the total share capital structure and voting power denominator, is a standard regulatory disclosure. While it touches upon share capital, it is specifically a notification about voting rights, which is a common component of general regulatory updates. Given the options, it is a regulatory announcement that doesn't fit perfectly into Share Issue/Capital Change (SHA) or Director's Dealing (DIRS). Since it is a standard, mandatory regulatory notification distributed via RNS, and the document itself is short and informational rather than a comprehensive report, it best fits the general regulatory filing category or a specific category if one applies better. The closest specific category related to share structure changes that might encompass this is 'SHA' (Share Issue/Capital Change), but this is specifically about the *voting rights denominator*. However, the presence of the RNS header and the nature of the disclosure strongly suggest a general regulatory filing. Since the document explicitly mentions 'RNS Number' and is a standard market notification, 'RNS' (Regulatory Filings) is the most appropriate fallback/general classification for this type of mandatory disclosure that isn't a full report or a specific event like a dividend or AGM.
2022-03-31 English
Block listing Interim Review
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'BLOCK LISTING SIX MONTHLY RETURN' and is issued via 'RNS Number', indicating a regulatory filing to the London Stock Exchange (LSE). It reports on the balance of unallotted securities under various share option schemes over a six-month period (15 September 2021 to 14 March 2022). This type of periodic return concerning share allotments and capital structure, especially when mandated by listing rules (implied by RNS/LSE context), fits best under a general regulatory announcement category. Since there is no specific code for a 'Block Listing Return', and it is a mandatory regulatory disclosure, the most appropriate classification is 'Regulatory Filings' (RNS), which serves as the general category for miscellaneous regulatory announcements not covered by more specific codes like 10-K or DIV.
2022-03-15 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 1038E' and contains the standard footer information stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content itself is a 'TR-1: Standard form for notification of major holdings,' detailing an acquisition or disposal of voting rights by an entity (abrdn plc affiliated entities) in Dechra Pharmaceuticals PLC. This type of mandatory disclosure regarding changes in significant share ownership thresholds directly corresponds to the Major Shareholding Notification category.
2022-03-09 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content focuses on notifying the market about the 'Total Voting Rights' as of a specific date (28 February 2022), referencing DTR 5.6.1R. This type of mandatory, short-form regulatory disclosure, which doesn't fit into specific financial reports (like 10-K or IR) or corporate actions (like DIV or SHA), is best classified under the general regulatory announcement category, RNS. Although it relates to share capital, it is a notification about voting rights denominator, not a transaction (POS) or a general share issue (SHA).
2022-02-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement from the London Stock Exchange, indicated by the 'RNS Number' and the footer information. The content is a 'TR-1: Standard form for notification of major holdings' concerning Dechra Pharmaceuticals PLC. This form reports changes in significant share ownership (crossing a threshold of 3.05% by Grandeur Peak Global Advisors, LLC). This type of mandatory disclosure regarding share ownership changes fits the definition of a regulatory filing that reports insider/major shareholder activity, but the most specific category for general regulatory announcements distributed via RNS, especially those concerning ownership changes that aren't explicitly covered by DIRS (Director's Dealing) or DEF 14A (Remuneration), is often best captured by the general regulatory filing category or the specific major shareholding notification category. Since 'Major Shareholding Notification' (MRQ) is an explicit category, and this document is precisely that—a notification of crossing a major holding threshold—MRQ is the most accurate classification. It is not a general 'Regulatory Filing' (RNS) fallback because a more specific code exists.
2022-02-24 English
HY2022 Half Yearly Financial Report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half-Yearly Financial Report 2022' and covers the six-month period ended 31 December 2021. It contains detailed financial statements, operational reviews, and performance highlights (revenue, operating profit, EPS). It is a comprehensive interim report rather than a mere announcement or summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-02-21 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.